UBS Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55M | Buy |
1,363,668
+948,817
| +229% | +$35.5M | 0.01% | 1550 |
|
|
2025
Q4 | $14.4M | Sell |
414,851
-135,087
| -25% | -$10.6M | ﹤0.01% | 2916 |
|
|
2025
Q3 | $45.7M | Buy |
549,938
+442,898
| +414% | +$32.1M | 0.01% | 1721 |
|
|
2025
Q2 | $7.86M | Sell |
107,040
-265,613
| -71% | -$19.3M | ﹤0.01% | 3366 |
|
|
2025
Q1 | $42.6M | Buy |
372,653
+122,491
| +49% | +$7.46M | 0.01% | 1629 |
|
|
2024
Q4 | $12.6M | Buy |
250,162
+71,966
| +40% | +$3.77M | ﹤0.01% | 2810 |
|
|
2024
Q3 | $8.25M | Buy |
178,196
+11,819
| +7% | +$420K | ﹤0.01% | 2551 |
|
|
2024
Q2 | $5.41M | Sell |
166,377
-2,957
| -2% | -$81K | ﹤0.01% | 2799 |
|
|
2024
Q1 | $4.27M | Buy |
169,334
+36,300
| +27% | +$858K | ﹤0.01% | 3138 |
|
|
2023
Q4 | $4.32M | Buy |
133,034
+64,483
| +94% | +$1.77M | ﹤0.01% | 2936 |
|
|
2023
Q3 | $1.87M | Buy |
68,551
+20,627
| +43% | +$597K | ﹤0.01% | 3503 |
|
|
2023
Q2 | $1.07M | Buy |
47,924
+13,493
| +39% | +$311K | ﹤0.01% | 4180 |
|
|
2023
Q1 | $746K | Buy |
34,431
+3,106
| +10% | +$68.1K | ﹤0.01% | 4364 |
|
|
2022
Q4 | $636K | Sell |
31,325
-1,826
| -6% | -$45.8K | ﹤0.01% | 4490 |
|
|
2022
Q3 | $850K | Buy |
33,151
+995
| +3% | +$26.6K | ﹤0.01% | 3883 |
|
|
2022
Q2 | $764K | Sell |
32,156
-210,835
| -87% | -$4.59M | ﹤0.01% | 3943 |
|
|
2022
Q1 | $5.47M | Buy |
242,991
+3,415
| +1% | +$72.6K | ﹤0.01% | 2449 |
|
|
2021
Q4 | $4.74M | Buy |
239,576
+201,964
| +537% | +$4.1M | ﹤0.01% | 2876 |
|
|
2021
Q3 | $741K | Sell |
37,612
-63,820
| -63% | -$1.34M | ﹤0.01% | 4438 |
|
|
2021
Q2 | $2.23M | Buy |
101,432
+59,863
| +144% | +$1.33M | ﹤0.01% | 3480 |
|
|
2021
Q1 | $989K | Buy |
41,569
+621
| +2% | +$16.6K | ﹤0.01% | 4255 |
|
|
2020
Q4 | $1.07M | Sell |
40,948
-1,052
| -3% | -$22.2K | ﹤0.01% | 3960 |
|
|
2020
Q3 | $731K | Sell |
42,000
-90,304
| -68% | -$1.44M | ﹤0.01% | 3877 |
|
|
2020
Q2 | $2.23M | Sell |
132,304
-185,279
| -58% | -$2.6M | ﹤0.01% | 2770 |
|
|
2020
Q1 | $3.78M | Buy |
317,583
+57,166
| +22% | +$707K | ﹤0.01% | 2165 |
|
|
2019
Q4 | $3.15M | Buy |
260,417
+106,234
| +69% | +$1.48M | ﹤0.01% | 3076 |
|
|
2019
Q3 | $2.18M | Buy |
154,183
+3,074
| +2% | +$37.8K | ﹤0.01% | 3202 |
|
|
2019
Q2 | $1.69M | Buy |
151,109
+82,891
| +122% | +$924K | ﹤0.01% | 3303 |
|
|
2019
Q1 | $801K | Sell |
68,218
-38,194
| -36% | -$475K | ﹤0.01% | 3741 |
|
|
2018
Q4 | $1.42M | Buy |
106,412
+46,847
| +79% | +$619K | ﹤0.01% | 3366 |
|
|
2018
Q3 | $835K | Sell |
59,565
-36,237
| -38% | -$506K | ﹤0.01% | 4010 |
|
|
2018
Q2 | $1.51M | Buy |
95,802
+40,715
| +74% | +$708K | ﹤0.01% | 3420 |
|
|
2018
Q1 | $906K | Sell |
55,087
-3,501
| -6% | -$64.9K | ﹤0.01% | 3794 |
|
|
2017
Q4 | $1.06M | Sell |
58,588
-17,639
| -23% | -$319K | ﹤0.01% | 3739 |
|
|
2017
Q3 | $1.47M | Buy |
76,227
+10,153
| +15% | +$151K | ﹤0.01% | 3381 |
|
|
2017
Q2 | $779K | Sell |
66,074
-2,696
| -4% | -$29.3K | ﹤0.01% | 3808 |
|
|
2017
Q1 | $754K | Sell |
68,770
-13,397
| -16% | -$118K | ﹤0.01% | 3747 |
|
|
2016
Q4 | $596K | Buy |
82,167
+10,849
| +15% | +$85K | ﹤0.01% | 3979 |
|
|
2016
Q3 | $464K | Sell |
71,318
-86,010
| -55% | -$500K | ﹤0.01% | 3961 |
|
|
2016
Q2 | $859K | Buy |
157,328
+44,940
| +40% | +$234K | ﹤0.01% | 3510 |
|
|
2016
Q1 | $526K | Sell |
112,388
-23,612
| -17% | -$92K | ﹤0.01% | 3735 |
|
|
2015
Q4 | $677K | Buy |
136,000
+23,888
| +21% | +$108K | ﹤0.01% | 3711 |
|
|
2015
Q3 | $421K | Buy |
112,112
+1,168
| +1% | +$5.93K | ﹤0.01% | 4047 |
|
|
2015
Q2 | $667K | Sell |
110,944
-11,805
| -10% | -$72.4K | ﹤0.01% | 3882 |
|
|
2015
Q1 | $688K | Sell |
122,749
-11,829
| -9% | -$42.8K | ﹤0.01% | 3889 |
|
|
2014
Q4 | $403K | Buy |
+134,578
| New | +$410K | ﹤0.01% | 4375 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
